Get the Scoop: Cytokinetics’ $450 Million Convertible Senior Notes Offering Priced!
Funny Findings in Biotech Pricing News Cytokinetics Announces Pricing! SOUTH SAN FRANCISCO, Calif., July 01, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced the pricing of their latest offering of a new drug that will revolutionize the market. The pricing news has sent shockwaves through the biotech industry, with analysts scrambling to…